150 related articles for article (PubMed ID: 34883291)
1. Small molecules with tetrahydroquinoline-containing Povarov scaffolds as inhibitors disrupting the Protein-RNA interaction of LIN28-let-7.
Goebel GL; Hohnen L; Borgelt L; Hommen P; Qiu X; Lightfoot H; Wu P
Eur J Med Chem; 2022 Jan; 228():114014. PubMed ID: 34883291
[TBL] [Abstract][Full Text] [Related]
2. Expanding the tetrahydroquinoline pharmacophore.
Goli N; Mainkar PS; Kotapalli SS; K T; Ummanni R; Chandrasekhar S
Bioorg Med Chem Lett; 2017 Apr; 27(8):1714-1720. PubMed ID: 28318941
[TBL] [Abstract][Full Text] [Related]
3. Spirocyclic Chromenopyrazole Inhibitors Disrupting the Interaction between the RNA-Binding Protein LIN28 and Let-7.
Borgelt L; Huang F; Hohnen L; Qiu X; Goebel GL; Hommen P; Wu P
Chembiochem; 2023 Sep; 24(17):e202300168. PubMed ID: 37129525
[TBL] [Abstract][Full Text] [Related]
4. Trisubstituted Pyrrolinones as Small-Molecule Inhibitors Disrupting the Protein-RNA Interaction of LIN28 and
Borgelt L; Li F; Hommen P; Lampe P; Hwang J; Goebel GL; Sievers S; Wu P
ACS Med Chem Lett; 2021 Jun; 12(6):893-898. PubMed ID: 34136077
[TBL] [Abstract][Full Text] [Related]
5. Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28.
Wang L; Rowe RG; Jaimes A; Yu C; Nam Y; Pearson DS; Zhang J; Xie X; Marion W; Heffron GJ; Daley GQ; Sliz P
Cell Rep; 2018 Jun; 23(10):3091-3101. PubMed ID: 29874593
[TBL] [Abstract][Full Text] [Related]
6. Identification of small molecule inhibitors of the Lin28-mediated blockage of pre-let-7g processing.
Lightfoot HL; Miska EA; Balasubramanian S
Org Biomol Chem; 2016 Nov; 14(43):10208-10216. PubMed ID: 27731469
[TBL] [Abstract][Full Text] [Related]
7. Free energy perturbation guided Synthesis with Biological Evaluation of Substituted Quinoline derivatives as small molecule L858R/T790M/C797S mutant EGFR inhibitors targeting resistance in Non-Small Cell Lung Cancer (NSCLC).
Karnik KS; Sarkate AP; Tiwari SV; Azad R; Wakte PS
Bioorg Chem; 2021 Oct; 115():105226. PubMed ID: 34364055
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
Zacarías-Lara OJ; Méndez-Luna D; Martínez-Ruíz G; García-Sanchéz JR; Fragoso-Vázquez MJ; Bello M; Becerra-Martínez E; García-Vázquez JB; Correa-Basurto J
Anticancer Agents Med Chem; 2019; 19(6):760-771. PubMed ID: 30451119
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Small-Molecule Modulators of Protein-RNA Interactions by Fluorescence Intensity-Based Binding Assay.
Byun WG; Lim D; Park SB
Chembiochem; 2020 Mar; 21(6):818-824. PubMed ID: 31587454
[TBL] [Abstract][Full Text] [Related]
10. A Small-Molecule Inhibitor of Lin28.
Roos M; Pradère U; Ngondo RP; Behera A; Allegrini S; Civenni G; Zagalak JA; Marchand JR; Menzi M; Towbin H; Scheuermann J; Neri D; Caflisch A; Catapano CV; Ciaudo C; Hall J
ACS Chem Biol; 2016 Oct; 11(10):2773-2781. PubMed ID: 27548809
[TBL] [Abstract][Full Text] [Related]
11. Chromenopyrazole-Peptide Conjugates as Small-Molecule Based Inhibitors Disrupting the Protein-RNA Interaction of LIN28-let-7.
Hommen P; Hwang J; Huang F; Borgelt L; Hohnen L; Wu P
Chembiochem; 2023 Sep; 24(17):e202300376. PubMed ID: 37224100
[TBL] [Abstract][Full Text] [Related]
12. Design and development of Tetrahydro-Quinoline derivatives as dual mTOR-C1/C2 inhibitors for the treatment of lung cancer.
Chaube UJ; Rawal R; Jha AB; Variya B; Bhatt HG
Bioorg Chem; 2021 Jan; 106():104501. PubMed ID: 33280832
[TBL] [Abstract][Full Text] [Related]
13. Probing an Allosteric Pocket of CDK2 with Small Molecules.
Christodoulou MS; Caporuscio F; Restelli V; Carlino L; Cannazza G; Costanzi E; Citti C; Lo Presti L; Pisani P; Battistutta R; Broggini M; Passarella D; Rastelli G
ChemMedChem; 2017 Jan; 12(1):33-41. PubMed ID: 27860401
[TBL] [Abstract][Full Text] [Related]
14. Identification of Phenazine-Based MEMO1 Small-Molecule Inhibitors: Virtual Screening, Fluorescence Polarization Validation, and Inhibition of Breast Cancer Migration.
Labrecque CL; Hilton CN; Airas J; Blake A; Rubenstein KJ; Parish CA; Pollock JA
ChemMedChem; 2021 Apr; 16(7):1163-1171. PubMed ID: 33332774
[TBL] [Abstract][Full Text] [Related]
15. Identification of small molecule inhibitors of Zcchc11 TUTase activity.
Lin S; Gregory RI
RNA Biol; 2015; 12(8):792-800. PubMed ID: 26114892
[TBL] [Abstract][Full Text] [Related]
16. LIN28/
Chen Y; Xie C; Zheng X; Nie X; Wang Z; Liu H; Zhao Y
Cancer Immunol Res; 2019 Mar; 7(3):487-497. PubMed ID: 30651289
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of tetrahydroquinoline-based reversible LSD1 inhibitors.
Wang X; Zhang C; Zhang X; Yan J; Wang J; Jiang Q; Zhao L; Zhao D; Cheng M
Eur J Med Chem; 2020 May; 194():112243. PubMed ID: 32229389
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, mechanistic and histopathological studies of small-molecules of novel indole-2-carboxamides and pyrazino[1,2-a]indol-1(2H)-ones as potential anticancer agents effecting the reactive oxygen species production.
Youssif BGM; Abdelrahman MH; Abdelazeem AH; Abdelgawad MA; Ibrahim HM; Salem OIA; Mohamed MFA; Treambleau L; Bukhari SNA
Eur J Med Chem; 2018 Feb; 146():260-273. PubMed ID: 29407956
[TBL] [Abstract][Full Text] [Related]
19. Structure-based discovery of novel 4-(2-fluorophenoxy)quinoline derivatives as c-Met inhibitors using isocyanide-involved multicomponent reactions.
Nan X; Li HJ; Fang SB; Li QY; Wu YC
Eur J Med Chem; 2020 May; 193():112241. PubMed ID: 32200199
[TBL] [Abstract][Full Text] [Related]
20. Scaffold Repurposing of In-House Small Molecule Candidates Leads to Discovery of First-in-Class CDK-1/HER-2 Dual Inhibitors: In Vitro and In Silico Screening.
Elkamhawy A; Ammar UM; Paik S; Abdellattif MH; Elsherbeny MH; Lee K; Roh EJ
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
